Lymphedema outcomes in patients with head and neck cancer
- PMID: 25389318
- PMCID: PMC4397961
- DOI: 10.1177/0194599814558402
Lymphedema outcomes in patients with head and neck cancer
Abstract
Objective: We sought to describe the presentation of external head and neck lymphedema in patients treated for head and neck cancer and to examine their initial responses to complete decongestive therapy.
Study design: Case series with chart review.
Setting: MD Anderson Cancer Center, Houston, Texas.
Subjects and methods: The charts of patients who were evaluated for head and neck cancer at MD Anderson Cancer Center after treatment (January 2007-January 2013) were retrospectively reviewed. Response to complete decongestive therapy was evaluated per changes in lymphedema severity rating or surface tape measures. Predictors of therapy response were examined on the basis of regression models.
Results: The cases of 1202 patients were evaluated. Most patients (62%) had soft reversible pitting edema (MD Anderson Cancer Center stage 1b). Treatment response was evaluated for 733 patients; 439 (60%) improved after complete decongestive therapy. Treatment adherence independently predicted complete decongestive therapy response (P < .001).
Conclusions: These data support the effectiveness of a head and neck cancer-specific regimen of lymphedema therapy for cancer patients with external head and neck lymphedema. Our findings suggest that head and neck lymphedema is distinct from lymphedema that affects other sites, thus requiring adaptations in traditional methods of management and measurement.
Keywords: cancer; head and neck; lymphedema; manual lymphatic drainage; treatment.
© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2014.
Figures
Similar articles
-
The Effects of Clinical and Home-based Physiotherapy Programs in Secondary Head and Neck Lymphedema.Laryngoscope. 2021 May;131(5):E1550-E1557. doi: 10.1002/lary.29205. Epub 2020 Oct 28. Laryngoscope. 2021. PMID: 33111977 Clinical Trial.
-
Effect of Complex Decongestive Therapy on Quality of Life and Physical Parameters in Head and Neck Lymphedema.Laryngoscope. 2024 Jul;134(7):3152-3157. doi: 10.1002/lary.31318. Epub 2024 Feb 2. Laryngoscope. 2024. PMID: 38308440
-
Treatment approaches and outcomes of a head and neck lymphedema service at an Australian comprehensive cancer center.Head Neck. 2023 Jun;45(6):1539-1548. doi: 10.1002/hed.27369. Epub 2023 Apr 17. Head Neck. 2023. PMID: 37067075
-
[Head and neck lymphedema. Literature review].Stomatologiia (Mosk). 2021;100(3):103-108. doi: 10.17116/stomat2021100031103. Stomatologiia (Mosk). 2021. PMID: 34180633 Review. Russian.
-
Managing lymphoedema following treatment for head and neck cancer: is complete decongestive therapy an effective intervention to improve dysphagia outcomes?Curr Opin Otolaryngol Head Neck Surg. 2024 Jun 1;32(3):178-185. doi: 10.1097/MOO.0000000000000969. Epub 2024 Feb 23. Curr Opin Otolaryngol Head Neck Surg. 2024. PMID: 38393685 Review.
Cited by
-
Head and neck cancer survivorship consensus statement from the American Head and Neck Society.Laryngoscope Investig Otolaryngol. 2021 Nov 30;7(1):70-92. doi: 10.1002/lio2.702. eCollection 2022 Feb. Laryngoscope Investig Otolaryngol. 2021. PMID: 35155786 Free PMC article. Review.
-
Management of the positive sentinel lymph node in the post-MSLT-II era.J Surg Oncol. 2020 Dec;122(8):1778-1784. doi: 10.1002/jso.26200. Epub 2020 Sep 6. J Surg Oncol. 2020. PMID: 32893366 Free PMC article.
-
Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.Head Neck. 2016 Dec;38(12):1765-1771. doi: 10.1002/hed.24529. Epub 2016 Jul 9. Head Neck. 2016. PMID: 27394060 Free PMC article.
-
Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial.Support Care Cancer. 2021 Feb;29(2):795-803. doi: 10.1007/s00520-020-05540-8. Epub 2020 Jun 2. Support Care Cancer. 2021. PMID: 32488435 Free PMC article. Clinical Trial.
-
A randomized pilot study on self-management in head and neck lymphedema.Laryngoscope Investig Otolaryngol. 2020 Sep 15;5(5):879-889. doi: 10.1002/lio2.455. eCollection 2020 Oct. Laryngoscope Investig Otolaryngol. 2020. PMID: 33134535 Free PMC article.
References
-
- Buntzel J, Glatzel M, Mucke R, Micke O, Bruns F. Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study. Anticancer Res. 2007;27:1953–1956. - PubMed
-
- Deng J, Ridner SH, Dietrich MS, et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage. 2012;43:244–252. - PubMed
-
- Földi M, Földi E. Physiology and pathophysiology of the lymphatic system. In: Földi M, Földi E, editors. Földi's textbook of lymphology; for physicians and lymphedema therapists. 2nd ed. Urban and Fischer; Munich, Germany: 2006. pp. 180–222.
-
- Zuther J. Anatomy. In: Zuther J, Norton S, editors. Lymphedema management: The comprehensive guide for practitioners. Thieme; New York: 2013. pp. 1–27.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical